Literature DB >> 6538314

Correlating auditory evoked and brainstem histologic abnormalities in infantile Gaucher's disease.

D J Lacey, K Terplan.   

Abstract

In an infant with Gaucher's disease, brainstem auditory evoked responses were abnormal on three separate occasions. Only waves I and II were typically present at standard intensity settings, although a third peak was elicited at 88 dB. Histologic studies demonstrated absence of neurons in the cochlear nuclei and a hypoplastic superior olivary complex. This neurophysiologic-pathologic correlation supports contentions that both brainstem auditory evoked response (BAER) waves I and II arise from the auditory nerve and that it may be capable of generating additional peaks.

Entities:  

Mesh:

Year:  1984        PMID: 6538314     DOI: 10.1212/wnl.34.4.539

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.

Authors:  Azza Abdel Gawad Tantawy; Eman Mounir Sherif; Amira Abdel Moneam Adly; Sahar Hassanine; Amina Hafez Awad
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

2.  A model of neuronopathic Gaucher disease.

Authors:  P E Campbell; C M Harris; C M Harris; T Sirimanna; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Vestibular and Saccadic Abnormalities in Gaucher's Disease.

Authors:  Luke Chen; G Michael Halmagyi; Michael J Todd; Swee T Aw
Journal:  JIMD Rep       Date:  2013-10-20

4.  Hearing loss in Pompe disease revisited: results from a study of 24 children.

Authors:  Carine I van Capelle; Andre Goedegebure; Nienke C Homans; Hans L J Hoeve; Arnold J Reuser; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2010-07-02       Impact factor: 4.982

5.  The saccadic and neurological deficits in type 3 Gaucher disease.

Authors:  William Benko; Markus Ries; Edythe A Wiggs; Roscoe O Brady; Raphael Schiffmann; Edmond J Fitzgibbon
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.